With the UN meeting on AIDS funding this week, CFR’s Laurie Garrett says the slow response to the AIDS epidemic was the single biggest failure in public health and argues the need to double funding for new treatments to stop the spread of the disease.
International donor support for fighting HIV has flat-lined, yet the United States--the world’s largest donor--is under fire from the global community, and domestic political support for Obama administration global health funding is flagging, writes CFR’s Laurie Garrett.
The global fight against HIV and AIDS cannot be won without success in South Africa, but while President Zuma’s government has made progress, it has to do more to prevent future infections and provide better treatment, says CFR’s Peter Navario.
This meeting is part of the CEO speaker series. This series provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.
Watch GlaxoSmithKline CEO Andrew Witty discuss steps GSK is taking to address neglected tropical diseases and to ensure access to vaccines in the developing world.
This session was part of the Corporate Program's CEO Speaker series.